Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Comparison of serum oxidant and antioxidant parameters in familial Mediterranean fever patients (FMF) with attack free period.
[familial mediterranean fever]
Objective
:
Familial
Mediterranean
fever
(
FMF
)
is
an
autoinflammatory
,
autosomal
recessive
,
inherited
disease
characterized
by
recurrent
self-limiting
attacks
of
serosal
surfaces
.
The
imbalance
of
oxidants
/
antioxidants
may
play
a
role
in
such
attacks
.
In
this
study
,
we
aimed
to
evaluate
the
relationship
between
serum
paraoxonase
(
PON
1
)
activity
,
PON
1
phenotype
,
and
other
parameters
in
patients
with
FMF
and
healthy
controls
.
Methods
:
A
total
of
120
FMF
patients
with
an
attack-free
period
(
AFP
)
and
65
healthy
subjects
were
included
in
this
study
.
The
serum
PON
1
activity
,
stimulated
paraoxonase
(
SPON
)
activity
,
PON
1
phenotype
(
representing
Q
192
R
polymorphism
;
QQ
,
QR
,
RR
)
,
arylesterase
activity
,
total
oxidant
status
(
TOS
)
,
total
antioxidant
capacity
(
TAC
)
,
oxidative
stress
index
(
OSI
)
,
advanced
oxidative
protein
products
(
AOPP
)
,
total
thiols
(
TTL
)
,
and
ischemia-modified
albumin
(
IMA
)
and
cystatin-c
(
CYS-C
)
levels
were
measured
.
Results
:
For
the
QQ
phenotype
,
the
median
TTL
and
AOPP
levels
of
the
control
group
were
264
.
50
(
57
.
75
)
µmol
/
L
and
21
.
26
(
21
.
17
)
mmol
/
L
,
respectively
,
whereas
the
median
TTL
,
AOPP
levels
of
the
patients
were
309
.
00
(
47
.
00
)
µmol
/
L
and
12
.
98
(
6
.
96
)
mmol
/
L
,
respectively
.
There
was
a
statistically
significant
difference
between
the
patients
and
controls
with
the
QQ
phenotype
in
terms
of
TTL
and
AOPP
(
p
<
0
.
001
and
p
=
0
.
004
,
respectively
)
.
However
,
there
were
no
statistically
significant
differences
between
the
QQ
and
QR
+
RR
phenotypes
with
respect
to
TAC
,
TOS
,
OSI
,
or
the
other
parameters
.
Conclusions
:
The
FMF
patients
with
AFP
had
higher
TTL
and
lower
AOPP
levels
than
the
controls
.
However
,
other
oxidant
and
antioxidant
parameters
were
similar
among
the
patients
during
AFP
and
the
controls
.
Diseases
Validation
Diseases presenting
"fever"
symptom
22q11.2 deletion syndrome
acute rheumatic fever
alexander disease
allergic bronchopulmonary aspergillosis
canavan disease
carcinoma of the gallbladder
child syndrome
congenital toxoplasmosis
cushing syndrome
cystinuria
dracunculiasis
erdheim-chester disease
esophageal adenocarcinoma
esophageal carcinoma
familial mediterranean fever
focal myositis
hodgkin lymphoma, classical
lamellar ichthyosis
legionellosis
locked-in syndrome
malignant atrophic papulosis
neonatal adrenoleukodystrophy
neuralgic amyotrophy
oculocutaneous albinism
papillon-lefèvre syndrome
pyomyositis
pyruvate dehydrogenase deficiency
scrub typhus
severe combined immunodeficiency
sneddon syndrome
systemic capillary leak syndrome
triple a syndrome
typhoid
waldenström macroglobulinemia
wolf-hirschhorn syndrome
This symptom has already been validated